Binbin Cheng

5PUBLICATIONS
6CO-AUTHORS
Major global burdens of diseaseBiologically active moleculesMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 01, 2026
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

|Feb 16, 2026
Discovery of Novel Heterotetracyclic DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Improved Oral Bioavailability and Potent Cancer Immunotherapy-Potentiating Activity.

Bingsheng Guan, Binbin Cheng, Shiyun Cheng

|Jun 26, 2025
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy.

Binbin Cheng, Yaping Wang, Yimeng Hong

|Feb 20, 2025
Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.

Zhihao Hu, Shuqing Li, Haiqi He

Pageof 1

Frequent Collaborators

3 joint publications

Jianjun Chen

2 joint publications

Xiaopeng Peng

1 joint publications

Wei Wang

1 joint publications

Xiaoge Niu